Skip These Biotech ...
Open Question
Scott:
What's your take on PRGO, SON & MKC? I have been looking @ them this morning.
Thinking these might be good plays in this crummy economy.
Page 1 of 1
Follow up: TEVA is the one of the best managed generic pharmaceutical companies
in the world, and MJN is holding its recent IPO price which is a positive sign
in a bad market.
Answered by Scott Rothbort / Lake View Asset Management, LLC
-
Bookmark this User
-
Ignore this user
1 months ago - Report Abuse
1 months ago - Report Abuse
Rate Now:
Average Rating: 0.00 / 0
PRGO - generic pharma and nutritional products. I would rather see you in Teva
Pharmaceuticals (TEVA) and Mead Johnson (MJH). SON - I have no opinion or feel.
MKC - a well managed company that will likely benefit from the downturn on the
casual dining segment of the restaurant market. I do not own it but would not
blame you from taking a position.
Answered by Scott Rothbort / Lake View Asset Management, LLC
-
Bookmark this User
-
Ignore this user
1 months ago - Report Abuse
1 months ago - Report Abuse
Rate Now:
Average Rating: 0.00 / 0
Page 1 of 1
